Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

The Department of Health and Human Services’ Administration for Strategic Preparedness and Response June 5 announced it selected two locations to test an automated, point-of-care, sterile saline ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

NRx Pharmaceuticals (NASDAQ: NRXP), has submitted an Abbreviated New Drug Application (ANDA) to the FDA for NRX-100, its ...

Expanding hospital-based pharmacies may increase medication adherence, reduce hospital admissions, improve access and ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: ...

Two Itochu Corp. units are expanding into the business of luring more foreign drug companies to Japan, in a bid to help them ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

The European Commission (EC) has approved Adcetris (brentuximab vedotin) in combination with etoposide, cyclophosphamide, ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

Discover trends shaping the pharmaceutical sector. Get insights on rising prescription drug prices, supply chains, and growth ...